Developer docs
API playgroundTry for free, no card

Search company profiles

Hepatitis B Foundation

Full company profile

uuid000lpez

Namestring
Hepatitis B Foundation
Websiteurl
hepb.org
Company typeenum
Private
Founded yearint
1991
Descriptiontext

The Hepatitis B Foundation is a US-based nonprofit organization headquartered in Doylestown, Pennsylvania, founded in 1991, with a stated mission of finding a cure for hepatitis B and improving the lives of those affected by the disease. It operates with a small staff of 1–10 employees and is led by co-founder Timothy Block in the role of president. Its functional remit spans patient advocacy, education, and research support targeted at the hepatitis B community — patients, families, caregivers, clinicians, and biomedical researchers working on the disease. As a 501(c)-style mission organization rather than a commercial enterprise, its revenue mechanics rely on donations, grants, and program partnerships rather than product pricing or licensing, and the input material does not disclose specific funding sources, program revenue, or partner logos.

There are no products, services, technology platforms, APIs, or proprietary software components described in the source data; the public website (hepb.org) returned only a loading/verification page rather than content, and no applications, integrations, certifications, patents, or trademarks were identified. No subsidiaries, parent entities, funding rounds, mergers, acquisitions, regulatory actions, or leadership changes beyond the original 1991 founding of Block are documented in the input. As a result, the verifiable analytical surface is limited to firmographic attributes (nonprofit, founded 1991, 1–10 employees, Doylestown, PA), the founder/president identity, and the disease-vertical mission, with no quantitative operating or financial data available to substantiate further claims.

Short descriptiontext

The Hepatitis B Foundation is a US nonprofit founded in 1991 in Doylestown, Pennsylvania, dedicated to finding a cure for hepatitis B and supporting affected patients, families, clinicians, and researchers in that disease community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDoylestown, United States
HQ citystring
Doylestown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
hepatitis B research, disease advocacy services, biomedical research foundation, patient education resources, public health nonprofit
Industry2 codes
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
2Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryNo
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Grantmaking Foundations813211
SIC code1 code
  • Services-Health Services8000
Product category
Nonprofit Health Advocacy
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Hepatitis B Foundation is a nonprofit organization that conducts and funds biomedical research aimed at finding a cure for hepatitis B. It also delivers patient education, provider training, public awareness, and policy advocacy programs designed to improve the quality of life and outcomes for individuals affected by hepatitis B worldwide.

Differentiator
Functional benefit
Problem solved
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Massive, broad-scope health research and advocacy nonprofit. Comparable as a disease-focused research funder with a far larger scale, donor base, and policy footprint.

TypeDirect peer
Description

Disease-specific research foundation dedicated to HIV/AIDS cure and treatment. Comparable as a vertically focused nonprofit funding cure-oriented research for a single infectious disease.

TypeDirect peer
Description

Nonprofit focused on liver health including viral hepatitis advocacy and policy. Comparable as a patient-centered liver/hepatitis advocacy and policy organization.

TypeBroad incumbent
Description

Larger national nonprofit addressing all liver diseases, including hepatitis B. Overlaps with the Hepatitis B Foundation's patient education and research funding mission but serves a broader disease portfolio.

TypeOthers
Description

Global public health body setting hepatitis B elimination targets and coordinating member-state programs. Related as a normative and convening actor in the hepatitis B ecosystem.

TypeRegional player
Description

Regional liver-focused nonprofit foundations outside the U.S. serving as counterparts for international hepatitis B advocacy and patient support, comparable in mission if not geography.

TypeOthers
Description

Federal research funding agency supporting hepatitis B and liver disease research. Related as a primary source of research grants and a counterpart in the hepatitis research ecosystem.

TypeDirect peer
Description

Disease-specific research and advocacy nonprofit that has successfully funded curative therapy development. Comparable as a single-disease research foundation model targeting a cure.

TypeDirect peer
Description

Coalition and advocacy organization dedicated to viral hepatitis elimination in the U.S. Overlaps with Hepatitis B Foundation in policy advocacy and awareness for hepatitis B.

TypeDirect peer
Description

Another U.S.-based nonprofit dedicated to hepatitis education, support, and advocacy. Directly comparable as a hepatitis-focused nonprofit competing for similar patient, donor, and awareness audiences.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hepatitis B Foundation

Nonprofit Health Advocacyhepb.org

The Hepatitis B Foundation is a US nonprofit founded in 1991 in Doylestown, Pennsylvania, dedicated to finding a cure for hepatitis B and supporting affected patients, families, clinicians, and researchers in that disease community.

What Hepatitis B Foundation does

The Hepatitis B Foundation is a US-based nonprofit organization headquartered in Doylestown, Pennsylvania, founded in 1991, with a stated mission of finding a cure for hepatitis B and improving the lives of those affected by the disease. It operates with a small staff of 1–10 employees and is led by co-founder Timothy Block in the role of president. Its functional remit spans patient advocacy, education, and research support targeted at the hepatitis B community — patients, families, caregivers, clinicians, and biomedical researchers working on the disease. As a 501(c)-style mission organization rather than a commercial enterprise, its revenue mechanics rely on donations, grants, and program partnerships rather than product pricing or licensing, and the input material does not disclose specific funding sources, program revenue, or partner logos.

There are no products, services, technology platforms, APIs, or proprietary software components described in the source data; the public website (hepb.org) returned only a loading/verification page rather than content, and no applications, integrations, certifications, patents, or trademarks were identified. No subsidiaries, parent entities, funding rounds, mergers, acquisitions, regulatory actions, or leadership changes beyond the original 1991 founding of Block are documented in the input. As a result, the verifiable analytical surface is limited to firmographic attributes (nonprofit, founded 1991, 1–10 employees, Doylestown, PA), the founder/president identity, and the disease-vertical mission, with no quantitative operating or financial data available to substantiate further claims.

Hepatitis B Foundation firmographics

Firmographics
Name
Hepatitis B Foundation
Website
https://hepb.org
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
1–10 employees
Short description
The Hepatitis B Foundation is a US nonprofit founded in 1991 in Doylestown, Pennsylvania, dedicated to finding a cure for hepatitis B and supporting affected patients, families, clinicians, and researchers in that disease community.
Ownership category
akta.pro rank

Hepatitis B Foundation industry classification

Industry
Product category
Nonprofit Health Advocacy
NAICS
Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
SIC
Services-Health Services (8000)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
akta.pro secondary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

  • Hepatitis B research
  • Disease advocacy services
  • Biomedical research foundation
  • Patient education resources
  • Public health nonprofit

Where Hepatitis B Foundation is headquartered

Location

Headquarters

HQ city
Doylestown
HQ country
United States
HQ region
North America

Markets served

Hepatitis B Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Hepatitis B Foundation product offering

Product offering

Core offering

Hepatitis B Foundation is a nonprofit organization that conducts and funds biomedical research aimed at finding a cure for hepatitis B. It also delivers patient education, provider training, public awareness, and policy advocacy programs designed to improve the quality of life and outcomes for individuals affected by hepatitis B worldwide.

Differentiator

Problem solved

Functional benefit

Companies that use Hepatitis B Foundation

Customer profile

Ideal customer profiles1 record

Hepatitis B Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hepatitis B Foundation partnerships and signals

Strategic signal

Recent moves1 record

Hepatitis B Foundation competitors and assessment

Company assessment

Broad incumbents

  • American Cancer Society: Massive, broad-scope health research and advocacy nonprofit. Comparable as a disease-focused research funder with a far larger scale, donor base, and policy footprint.
  • American Liver Foundation: Larger national nonprofit addressing all liver diseases, including hepatitis B. Overlaps with the Hepatitis B Foundation's patient education and research funding mission but serves a broader disease portfolio.

Direct peers

  • amfAR (Foundation for AIDS Research): Disease-specific research foundation dedicated to HIV/AIDS cure and treatment. Comparable as a vertically focused nonprofit funding cure-oriented research for a single infectious disease.
  • Global Liver Institute: Nonprofit focused on liver health including viral hepatitis advocacy and policy. Comparable as a patient-centered liver/hepatitis advocacy and policy organization.
  • Cystic Fibrosis Foundation: Disease-specific research and advocacy nonprofit that has successfully funded curative therapy development. Comparable as a single-disease research foundation model targeting a cure.
  • National Viral Hepatitis Roundtable: Coalition and advocacy organization dedicated to viral hepatitis elimination in the U.S. Overlaps with Hepatitis B Foundation in policy advocacy and awareness for hepatitis B.
  • Hepatitis Foundation International: Another U.S.-based nonprofit dedicated to hepatitis education, support, and advocacy. Directly comparable as a hepatitis-focused nonprofit competing for similar patient, donor, and awareness audiences.

Others

Regional players

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Hepatitis B Foundation social profiles

Digital presence

Hepatitis B Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hepatitis B Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Hepatitis B Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hepatitis B Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hepatitis B Foundation

What does Hepatitis B Foundation do?

Hepatitis B Foundation is a nonprofit organization that conducts and funds biomedical research aimed at finding a cure for hepatitis B. It also delivers patient education, provider training, public awareness, and policy advocacy programs designed to improve the quality of life and outcomes for individuals affected by hepatitis B worldwide.

Is Hepatitis B Foundation a public or private company?

Hepatitis B Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Hepatitis B Foundation founded?

Hepatitis B Foundation was founded in 1991. It employs 1 to 10 people.

Where is Hepatitis B Foundation based?

Hepatitis B Foundation is headquartered in Doylestown, United States, in the North America region.

Who are Hepatitis B Foundation's main competitors?

Broad incumbents on record are American Cancer Society and American Liver Foundation. Direct peers are amfAR (Foundation for AIDS Research), Global Liver Institute, Cystic Fibrosis Foundation, National Viral Hepatitis Roundtable and Hepatitis Foundation International. Others are World Health Organization Global Hepatitis Programme and National Institutes of Health (NIDDK / NIAID). Liver Foundation of South Africa / similar regional liver foundations is listed as a regional player.

Does Hepatitis B Foundation have an API?

No public API is recorded for Hepatitis B Foundation.

What industry is Hepatitis B Foundation in?

Hepatitis B Foundation's product category is Nonprofit Health Advocacy. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAdvancing Research, Awareness, Screening and Linkage to Care to Eliminate Hep D in the U.S. is CriticalThe American Liver Foundation and Hepatitis B Foundation published a roundtable report in Hepatology Communications outlining five priority areas to eliminate hepatitis delta (HDV) in the U.S. The recommendations urge lawmakers and healthcare providers to improve awareness, simplify screening protocols, and expand research into linkage to care and new therapies. This initiative aims to address the lack of FDA-approved treatments and increase public understanding of HDV's aggressive progression.GlobeNewswireArbutus Recognizes Liver Cancer Awareness Month with Grant to Support the Hepatitis B Foundation’s Patient Storytelling CampaignArbutus Biopharma announced a grant to the Hepatitis B Foundation to support its Patient Storytelling Campaign, which aims to raise awareness about chronic hepatitis B and reduce stigma. The campaign is part of Liver Cancer Awareness Month, as chronic HBV is the leading cause of primary liver cancer.PR NewswireEiger BioPharmaceuticals Announces Partnership with the Hepatitis B FoundationEiger BioPharmaceuticals announced a partnership with the Hepatitis B Foundation to launch a hepatitis delta disease awareness and testing program in support of World Hepatitis Day 2016. The initiative aims to increase awareness and improve access to quantitative HDV-RNA testing methodologies, which are currently limited in the US market. This collaboration supports the commercialization of these diagnostic tools to better manage hepatitis delta, the deadliest form of viral hepatitis.